Stay updated on Dose Dense Paclitaxel with Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page.

Latest updates to the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows that recruitment has closed and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) with a revised Intervention/Treatment heading, while removing the old heading and the prior revision reference.SummaryDifference0.4%

- Check21 days agoChange DetectedRevision: v3.5.5 replaces v3.5.4. This reflects a new build of the page without changes to study content.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, reflecting a newer build of the site's interface. This behind-the-scenes update does not modify the trial details or any user-facing content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page's revision label updated from v3.5.2 to v3.5.3, indicating a small content/metadata update.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded related-topic links for “Ovarian cancer” to MedlinePlus Genetics. This is informational cross-referencing and does not alter the study’s substantive details.SummaryDifference0.2%

- Check71 days agoChange DetectedRevision: v3.5.2 has been added. Ovarian cancer, related topics (MedlinePlus Genetics), and Revision: v3.5.0 have been removed.SummaryDifference0.2%

Stay in the know with updates to Dose Dense Paclitaxel with Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Dense Paclitaxel with Pembrolizumab Clinical Trial page.